Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2008
12/03/2008EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof
12/03/2008CN101316613A Gastrointestinal function promoter
12/03/2008CN101316590A Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
12/03/2008CN101316589A 糖尿病的治疗 Treatment of diabetes
12/03/2008CN101316588A Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
12/03/2008CN101314038A Three scheme-in-one medicament
12/03/2008CN101314037A Medicament composition steadily containing angiotonin invertase restrainer
12/03/2008CN101313894A Freeze-dried injection of proton pump inhibitor
12/03/2008CN101313873A Biology polypeptide medicament blood vessel bracket and preparation method thereof
12/03/2008CN100439920C Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
12/03/2008CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer
12/03/2008CN100438913C Anti-cancer medicine composition
12/03/2008CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof
12/03/2008CN100438911C Body weight gain inhibitor
12/03/2008CN100438910C Preventives/remedies for liver diseases
12/03/2008CN100438908C CpG formulations and related methods
12/03/2008CN100438875C Methods for increasing the therapeutic response to electroconvulsive therapy
12/03/2008CN100438870C Method for treating diseases with omega interferon
12/03/2008CN100438861C Aqueous 2,6-diisopropylphenol pharmaceutical compositions
12/03/2008CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum
12/02/2008USRE40594 Inhibitors of the bitter taste response
12/02/2008US7460182 Circuit for processing video signal including information such as caption
12/02/2008US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459481 Adust fatty acid oxidation; stimulant of carnitine plamitoyl treansferrase
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459455 Pyrimidine compounds
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism
12/02/2008US7459428 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008US7459154 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
12/02/2008US7459151 Phosphate-binding polymers for oral administration
12/02/2008US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot
12/02/2008US7458982 Photokinetic delivery of biologically active substances using pulsed incoherent light
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2284170C Identification of agents for use in the treatment of alzheimer's disease
12/02/2008CA2263568C Methods for diagnostic imaging using a contrast agent and a renal vasodilator
12/02/2008CA2257803C Non immunosuppressive antifungal rapalogs
11/2008
11/27/2008WO2008144738A1 Method for pain control
11/27/2008WO2008144423A2 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer
11/27/2008WO2008144067A1 Methods and compositions for treatment of cancer using oncolytic rsv activity
11/27/2008WO2008144061A2 Novel combinations comprising a phosphodiesterase-5 inhibitor and their use
11/27/2008WO2008143916A2 Prokinetic agent for bowel preparation
11/27/2008WO2008143182A1 Composition containing licorice-derived polyphenol
11/27/2008WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
11/27/2008WO2008142513A2 Phosphate-modified oligonucleotide analogs with immunostimulatory activity
11/27/2008WO2008142094A1 Triazol compounds for treating biofilm formation
11/27/2008WO2008118733A3 Methods of treating cancer by administering human il-18 combinations
11/27/2008WO2008063849A3 Multiple sclerosis therapy
11/27/2008WO2008039472A3 Stabilizing compositions for antibiotics and methods of use
11/27/2008WO2007131253A3 Use of combination preparations comprising antifungal agents
11/27/2008US20080293847 Disinfecting polymer and articles made therefrom
11/27/2008US20080293830 Method For Activating Efferent Sympathetic Nerves Innervating Adipose Tissues To Improve Obesity And Symptoms Associated Therewith
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293788 Methods and Compositions for the Treatment of Pulmonary Diseases
11/27/2008US20080293703 Topical Preparation and Method for Transdermal Delivery and Localization of Therapeutic Agents
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
11/27/2008US20080293628 Methods and Compositions for the Inhibition of Thrombus Formation
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293034 Organ arrest, protection, preservation and recovery
11/27/2008US20080292714 Bone targeting of degradable drug filled nanoparticles
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292694 Opioid agonist/antagonist combinations
11/27/2008US20080292643 Leukocyte inactivation module
11/27/2008US20080292631 Treatment with anti-vegf antibodies
11/27/2008US20080292630 Treatment with anti-vegf antibodies
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292604 Canine probiotic lactobacilli
11/27/2008US20080292583 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione following autologous stem cell transplantation
11/27/2008US20080292562 Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008DE10251709B4 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
11/27/2008CA2687679A1 Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
11/27/2008CA2687535A1 Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity
11/27/2008CA2685826A1 Prokinetic agent for bowel preparation
11/27/2008CA2685112A1 Triazol compounds for treating biofilm formation
11/27/2008CA2684920A1 Methods of treating cognitive disorders by inhibition of gpr12
11/27/2008CA2684604A1 Methods and compositions for treating skin conditions
11/27/2008CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994936A1 Lactobacilli for the prevention of mastitis and for reducing the risk of allergy in breast-fed infants
11/26/2008EP1994930A1 Triazol compounds for treating biofilm formation
11/26/2008EP1993619A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
11/26/2008EP1993597A2 Human telomerase reverse transcriptase peptides
11/26/2008EP1993531A2 Extended cycle multiphasic oral contraceptive method
11/26/2008EP1993519A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products
11/26/2008EP1993514A2 Granular material comprising water-insoluble inorganic phosphate binders
11/26/2008EP1706122B1 Anti-viral pharmaceutical compositions
11/26/2008EP1546373B1 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
11/26/2008EP1523239B1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 1151